Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients

Pathological response of breast cancer to neoadjuvant chemotherapy (NAC) presents great variability, and new prognostic biomarkers are needed. Our aim was to evaluate the association of the epidermal growth factor receptor gene (EGFR) polymorphism R497K (rs2227983) with prognostic features and clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobral-Leite, Marcelo, Lips, Esther H., Vieira-Monteiro, Hayra de Andrade, Giacomin, Letícia Carlos, Freitas-Alves, Daniely Regina, Cornelissen, Sten, Mulder, Lennart, Wesseling, Jelle, Schmidt, Marjanka K., Vianna-Jorge, Rosane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739423/
https://www.ncbi.nlm.nih.gov/pubmed/29267323
http://dx.doi.org/10.1371/journal.pone.0189750

Ejemplares similares

Ejemplares similares